SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-151204
Filing Date
2021-12-17
Accepted
2021-12-17 16:55:20
Documents
12
Period of Report
2021-12-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135822d1_8k.htm   iXBRL 8-K 26024
  Complete submission text file 0001104659-21-151204.txt   198292

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bpth-20211216.xsd EX-101.SCH 3046
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20211216_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20211216_pre.xml EX-101.PRE 22373
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2135822d1_8k_htm.xml XML 3607
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 211502330
SIC: 2834 Pharmaceutical Preparations